MORGAN STANLEY - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 11 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2022$5,000
-16.7%
6,0000.0%0.00%
Q2 2022$6,0000.0%6,0000.0%0.00%
Q1 2022$6,0000.0%6,0000.0%0.00%
Q4 2021$6,0000.0%6,0000.0%0.00%
Q3 2021$6,000
+100.0%
6,000
+100.0%
0.00%
Q2 2021$3,000
-25.0%
3,000
-25.0%
0.00%
Q1 2021$4,000
-42.9%
4,000
-42.9%
0.00%
Q4 2020$7,0000.0%7,0000.0%0.00%
Q3 2020$7,000
-82.5%
7,000
-82.9%
0.00%
Q2 2020$40,000
-64.3%
41,000
-66.1%
0.00%
Q1 2020$112,000
+111.3%
121,000
+116.1%
0.00%
Q4 2019$53,000
+657.1%
56,000
+600.0%
0.00%
Q3 2019$7,000
-99.7%
8,000
-99.7%
0.00%
-100.0%
Q2 2019$2,411,000
+2072.1%
2,637,000
+2097.5%
0.00%
Q1 2019$111,000
+122.0%
120,000
+114.3%
0.00%
Q4 2018$50,000
-94.9%
56,000
-94.7%
0.00%
Q3 2018$984,000
+8845.5%
1,057,000
+8708.3%
0.00%
Q2 2018$11,000
-97.6%
12,000
-97.7%
0.00%
Q1 2018$459,000
+227.9%
520,000
+229.1%
0.00%
Q4 2017$140,000
-70.5%
158,000
-70.1%
0.00%
Q3 2017$475,000
+486.4%
529,000
+605.3%
0.00%
Q2 2017$81,000
+55.8%
75,000
+56.2%
0.00%
Q1 2017$52,000
-57.4%
48,000
-57.1%
0.00%
Q4 2016$122,000
+662.5%
112,000
+761.5%
0.00%
Q3 2016$16,000
+14.3%
13,000
+18.2%
0.00%
Q2 2016$14,000
-87.5%
11,000
-87.2%
0.00%
Q1 2016$112,000
+261.3%
86,000
+330.0%
0.00%
Q4 2015$31,000
+40.9%
20,000
+25.0%
0.00%
Q3 2015$22,000
+69.2%
16,000
+77.8%
0.00%
Q2 2015$13,000
-13.3%
9,000
-10.0%
0.00%
Q1 2015$15,000
-83.3%
10,000
-85.7%
0.00%
Q3 2014$90,000
+2900.0%
70,000
+3400.0%
0.00%
Q1 2014$3,000
-97.2%
2,000
-98.0%
0.00%
Q4 2013$107,000
+245.2%
101,000
+236.7%
0.00%
Q2 2013$31,00030,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q1 2022
NameSharesValueWeighting ↓
Arena Capital Advisors, LLC- CA 68,443,000$68,785,00010.97%
PIPER SANDLER & CO. 12,550,000$12,425,0008.95%
Radcliffe Capital Management, L.P. 100,783,000$100,279,0006.28%
INCOME RESEARCH & MANAGEMENT 14,775,000$14,701,0005.39%
PenderFund Capital Management Ltd. 4,000,000$5,123,0001.30%
Bracebridge Capital, LLC 5,500,000$5,390,0000.82%
Western Asset Management Company, LLC 9,000,000$8,916,0000.57%
WESTWOOD HOLDINGS GROUP INC 43,125,000$42,856,0000.49%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,050,000$1,045,0000.45%
JUPITER ASSET MANAGEMENT LTD 35,000,000$34,675,0000.35%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders